Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 12;6(2):36.
doi: 10.3390/ebj6020036.

Hand Function Recovers to Near Normal in Patients with Deep Dermal Hand Burns Treated with Enzymatic Debridement: A Prospective Cohort Study

Kelly Aranka Ayli Kwa  1   2 , Annika Catherina Reuvers  1   3 , Jorien Borst-van Breugel  1   4 , Anouk Pijpe  1   5   6 , Paul P M van Zuijlen  1   5   6   7   8 , Roelf S Breederveld  1   2 , Annebeth Meij-de Vries  1   8   9
Affiliations

Hand Function Recovers to Near Normal in Patients with Deep Dermal Hand Burns Treated with Enzymatic Debridement: A Prospective Cohort Study

Kelly Aranka Ayli Kwa et al. Eur Burn J. .

Abstract

Short- and long-term hand function was evaluated in adult patients with deep dermal and full-thickness hand burns after treatment with enzymatic debridement (NexoBrid® MediWound Ltd., Yavne, Israel), assessing the results at discharge and 3, 6, and 12 months post-burn. This prospective cohort study was performed in the Burn Center in Beverwijk between March 2017 and December 2019. Hand function was assessed using Modified Kapandji Index scores, the Jebsen-Taylor Hand Function Test, and range of motion; scar quality using the Patient and Observer Scar Assessment Scale version 2.0; and quality of life using the Quick Disability Arm Shoulder Hand Questionnaire and the Canadian Occupational Performance Measure. Ten patients (14 hand burns) were included. The need for a skin graft after NexoBrid® was 86%, and 50% needed additional surgical excision before skin grafting. Digits 3 and 4 achieved near-to-normal total active motion, and at least 50% of the hands achieved a normal range within the Jebsen-Taylor Hand Function Test in four items at 12 months post-burn. Scar quality and quality of life improved significantly over time. The present study can be considered as a proof-of-concept study for future clinical trials on enzymatic debridement for hand burns.

Keywords: burns; enzymatic debridement; hand function; quality of life; scar quality.

PubMed Disclaimer

Conflict of interest statement

Roelf S. Breederveld is the principal investigator at the local site (Red Cross Hospital, Beverwijk) that participated in the CIDS study (MW 2012-01-01), which is a multicenter, multinational, randomized, controlled, open-label study, performed in children with thermal burns to evaluate the efficacy and safety of NexoBrid compared to standard-of-care treatment. The CIDS study was initiated and is funded by Mediwound (Yavne, Israel), which is the manufacturer of NexoBrid. Kelly A. A. Kwa was a PhD candidate, not paid through the finances/grant received by Mediwound, who worked as a (local) researcher on the CIDS study. Prof. Paul P. M. van Zuijlen is the developer of the Patient and Observer Scar Assessment Scale.

Figures

Figure 1
Figure 1
Flowchart.
Figure 2
Figure 2
Evaluation of the hands after NexoBrid® treatment. (A) = flame burn; (B) = post-enzymatic debridement; (C) = 3 months post-burn; (D) = 6 months post-burn; (E) = 12 months post-burn.
Figure 3
Figure 3
Goniometry; median TAM over time. TAM = total active motion; 260° is considered normal. Friedman test, post hoc analysis, Wilcoxon signed-rank test, p < 0.0083. * Significant increase between the indicated months. ** Significant increase between every month, except between 3 and 6 months.
Figure 4
Figure 4
MKI scores and Q-DASH. MKI = Modified Kapandji Index. Q-DASH = Quick (shortened) Disability Arm Shoulder Hand Questionnaire. Friedman test, post hoc analysis, Wilcoxon signed-rank test. ● *compared to baseline; p < 0.0083. formula image ** significant for Q-DASH; p < 0.017.
Figure 5
Figure 5
POSAS scores over time. POSAS = Patient and Observer Scar Assessment Scale. Friedman test, * p < 0.05; post hoc analysis, Wilcoxon signed-rank test, p < 0.017, **** indicates statistical significance for all four items mentioned.
See this image and copyright information in PMC

References

    1. Bain C.J., Wang T., McArthur G., Williams G., Atkins J., Jones I. Safety and efficacy of excision and direct closure in acute burns surgery: Outcome analysis in a prospective series of 100 patients and a survey of UK burns surgeons’ attitudes. Burns. 2014;40:1635–1641. doi: 10.1016/j.burns.2014.02.021. - DOI - PubMed
    1. Bock O., Schmid-Ott G., Malewski P., Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch. Dermatol. Res. 2006;297:433–438. doi: 10.1007/s00403-006-0651-7. - DOI - PubMed
    1. Deitch E.A., Wheelahan T.M., Rose M.P., Clothier J., Cotter J. Hypertrophic burn scars: Analysis of variables. J. Trauma. 1983;23:895–898. doi: 10.1097/00005373-198310000-00009. - DOI - PubMed
    1. Muller M., Gahankari D., Herndon D.N. Operative Wound Management. In: Greenwood G., editor. Total Burn Care. 3rd ed. Philadelphia Saunders Elsevier; Beijing, China: 2007. pp. 177–195.
    1. Kwa K.A.A., Goei H., Breederveld R.S., Middelkoop E., van der Vlies C.H., van Baar M.E. A systematic review on surgical and nonsurgical debridement techniques of burn wounds. J. Plast. Reconstr. Aesthet. Surg. 2019;72:1752–1762. doi: 10.1016/j.bjps.2019.07.006. - DOI - PubMed

LinkOut - more resources